A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

Clinical trial NCT06423352 · COMPLETED

Trial details

NCT number: NCT06423352
Sponsor: Alnylam Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild to Moderate Hypertension

Start date: 2024-06-05
Primary completion: 2025-07-17
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.